​

Akoya Biosciences (AKYA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Akoya Biosciences Revenue Highlights

Latest Revenue (Y)

$96.63M

Latest Revenue (Q)

$18.81M

Main Segment (Y)

Product

Main Geography (Y)

North America

Akoya Biosciences Revenue by Period

Akoya Biosciences Revenue by Year

DateRevenueChange
2023-12-31$96.63M29.09%
2022-12-31$74.86M36.31%
2021-12-31$54.92M29.39%
2020-12-31$42.44M0.49%
2019-12-31$42.24M-

Akoya Biosciences generated $96.63M in revenue during NA 2023, up 29.09% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Akoya Biosciences Revenue by Quarter

DateRevenueChange
2024-09-30$18.81M-18.78%
2024-06-30$23.16M26.23%
2024-03-31$18.35M-30.72%
2023-12-31$26.49M5.04%
2023-09-30$25.21M7.20%
2023-06-30$23.52M9.86%
2023-03-31$21.41M0.90%
2022-12-31$21.22M12.56%
2022-09-30$18.85M5.35%
2022-06-30$17.89M5.92%
2022-03-31$16.89M4.56%
2021-12-31$16.16M19.90%
2021-09-30$13.48M3.10%
2021-06-30$13.07M7.03%
2021-03-31$12.21M-5.39%
2020-12-31$12.91M29.68%
2020-09-30$9.95M16.29%
2020-06-30$8.56M-22.33%
2020-03-31$11.02M-

Akoya Biosciences generated $18.81M in revenue during Q3 2024, up -18.78% compared to the previous quarter, and up 79.99% compared to the same period a year ago.

Akoya Biosciences Revenue Breakdown

Akoya Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Standalone software products$1.18M$636.00K$1.49M
Product$67.41M$57.65M$44.48M
Service and other$29.22M$17.21M$10.44M
Consumables$24.13M$18.38M$14.30M
Instruments$42.09M$38.63M$28.69M
Service And Other$18.93M--

Akoya Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (36.84%), Instruments (23.01%), Service and other (15.97%), Consumables (13.19%), Service And Other (10.35%), and Standalone software products (0.65%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Product$12.30M$12.14M$34.74M$17.15M$15.52M$15.71M$14.44M$14.16M$13.34M$12.92M$10.87M$10.72M$9.96M
Standalone software products$268.00K$270.00K$924.00K$52.00K$205.00K$39.00K$200.00K$203.00K$194.00K$409.00K---
Service and other$6.52M$6.21M$16.96M$6.37M$5.89M$5.51M$4.41M$3.73M$3.55M$3.24M---
Instruments$5.74M$4.87M$21.21M$11.28M$9.61M$11.14M$9.51M$9.46M$8.52M$8.50M$7.10M$6.26M$6.84M
Consumables$6.29M$7.00M$12.60M$5.82M$5.71M$4.53M$4.72M$4.50M$4.63M$4.01M$3.43M$4.31M$2.54M
Service And Other$3.73M$3.38M-----------
Standalone Software Products----------$345.00K$151.00K$582.00K
Service----------$2.60M$2.35M$2.25M

Akoya Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (35.30%), Service and other (18.70%), Consumables (18.06%), Instruments (16.47%), Service And Other (10.70%), and Standalone software products (0.77%).

Akoya Biosciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
EMEA$21.80M$17.75M$14.36M
North America$58.28M$42.05M$28.03M
APAC$16.55M$15.06M$12.53M

Akoya Biosciences's latest annual revenue breakdown by geography, as of Dec 23: North America (60.31%), EMEA (22.56%), and APAC (17.13%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
North America$10.59M$10.12M$32.62M$13.81M$11.85M$12.32M$10.92M$9.48M$9.32M$9.02M$7.39M$6.40M$5.21M
APAC$3.03M$3.27M$8.06M$4.11M$4.39M$3.47M$3.81M$4.27M$3.51M$3.00M---
EMEA$5.19M$4.96M$11.02M$5.60M$5.17M$5.43M$4.12M$4.14M$4.06M$4.13M---
E M E A----------$3.25M$3.66M$3.31M
Asia Pacific----------$2.83M$3.01M$3.69M

Akoya Biosciences's latest quarterly revenue breakdown by geography, as of Sep 24: North America (56.29%), EMEA (27.61%), and APAC (16.10%).

Akoya Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
COOCooper Companies$3.90B$1.00B
ATRAptarGroup$3.49B$909.29M
ICUIICU Medical$2.26B$589.13M
HAEHaemonetics$1.31B$336.17M
ATRCAtriCure$399.25M$115.91M
ANGOAngioDynamics$303.91M$72.84M
LMATLeMaitre Vascular$193.48M$54.82M
AKYAAkoya Biosciences$96.63M$18.81M
PDEXPro-Dex$53.84M$16.79M
UTMDUtah Medical Products$50.22M$10.01M

AKYA Revenue FAQ

What is Akoya Biosciences’s yearly revenue?

Akoya Biosciences's yearly revenue for 2023 was $96.63M, representing an increase of 29.09% compared to 2022. The company's yearly revenue for 2022 was $74.86M, representing an increase of 36.31% compared to 2021. AKYA's yearly revenue for 2021 was $54.92M, representing an increase of 29.39% compared to 2020.

What is Akoya Biosciences’s quarterly revenue?

Akoya Biosciences's quarterly revenue for Q3 2024 was $18.81M, a -18.78% decrease from the previous quarter (Q2 2024), and a -25.39% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $23.16M, a 26.23% increase from the previous quarter (Q1 2024), and a -1.52% decrease year-over-year (Q2 2023). AKYA's quarterly revenue for Q1 2024 was $18.35M, a -30.72% decrease from the previous quarter (Q4 2023), and a -14.29% decrease year-over-year (Q1 2023).

What is Akoya Biosciences’s revenue growth rate?

Akoya Biosciences's revenue growth rate for the last 3 years (2021-2023) was 75.96%, and for the last 5 years (2019-2023) was 128.79%.

What are Akoya Biosciences’s revenue streams?

Akoya Biosciences's revenue streams in c 23 are Standalone software products, Product, Service and other, Consumables, Instruments, and Service And Other. Standalone software products generated $1.18M in revenue, accounting 0.65% of the company's total revenue, up 85.69% year-over-year. Product generated $67.41M in revenue, accounting 36.84% of the company's total revenue, up 16.93% year-over-year. Service and other generated $29.22M in revenue, accounting 15.97% of the company's total revenue, up 69.81% year-over-year. Consumables generated $24.13M in revenue, accounting 13.19% of the company's total revenue, up 31.31% year-over-year. Instruments generated $42.1M in revenue, accounting 23.01% of the company's total revenue, up 8.96% year-over-year. Service And Other generated $18.93M in revenue, accounting 10.35% of the company's total revenue

What is Akoya Biosciences’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Akoya Biosciences was Product. This segment made a revenue of $67.41M, representing 36.84% of the company's total revenue.